Tele-imaging holds promise for rural patients

Article

ing a presentation at SECO on Friday, Tony Cavallerano, OD, FAAO, said tele-imaging will help break down access to care barriers, especially for those in rural and underserved communities.

Atlanta, GA-During a presentation at SECO on Friday, Tony Cavallerano, OD, FAAO, said tele-imaging will help break down access to care barriers, especially for those in rural and underserved communities.

Through tele-imaging, a patient can go to a primary care doctor for the imaging, and the images are sent on to an eyecare professional. Dr. Cavallerano spoke primarily on monitoring patients with diabetes but said it would also work for imaging macula and the optic nerve.

Dr. Cavallerano says tele-retinal imaging is a viable option to screen for important sight-threatening conditions. As the population ages, this changing demographic will drive the need to conduct more retinal screenings.

But standardization and validation is critical for maintaining high levels of sensitivity and specificity.

“Some day we may even be doing eye exams using telemedicine, although nothing can replace the critical thinking and reasoning skills we develop along the way throughout our careers,” says Dr. Cavallerano.

Dr. Cavallerano says he believes large imaging devices will soon become a thing of the past, and he envisions a day when a patient would take a “selfie” of her own retina. 

Recent Videos
Jennifer Li, MD, details a talk she gave alongside Melissa Barnett, OD, FAAO, FSLS, FBCLA, at CRU 2025 in Napa, California.
Deb Ristvedt, DO, details a handful of presentations on glaucoma she gave during CRU 2025 in Napa, California.
Cecelia Koetting, OD, FAAO, DipABO, weighs in on patient assessments, staining pattern insights, and diagnostic tips for patients who may have dry eye disease.
Melissa Barnett, OD, FAAO, FSLS, FBCLA, discusses keratoconus management, diagnosis, and other key insights at CRU 2025.
Cecelia Koetting, OD, FAAO, DipABO, details a talk she gave among optometrists and ophthalmologists at CRU 2025.
Alongside Rachelle Lin, OD, MS, FAAO; Nguyễn, MD, MSc, detailed what treatments are currently available for retinal vascular diseases, including neovascular age-related macular degeneration and diabetic retinopathy.
Dr Paul Karpecki discusses atropine formulation from Sydnexis following NDA acceptance by FDA
Ali Tafreshi sits down with Optometry Times to discuss Topcon's "Healthcare from the Eye" initiative.
Nora Lee Cothran, OD, FAAO, details a real-world study that found IOP-lowering benefits when switching patients with glaucoma to latanoprostene bunod treatment.
OptiLIFT in action: Dr. Julie McLaughlin's experience with the new device
© 2025 MJH Life Sciences

All rights reserved.